Myrbetriq is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Image of Stuffed French Toast

Stuffed French Toast

Prep: 20 minutes
Cook: 45 minutes
Serves: 6

Image of some eggs

Ingredients

  • 12 slices of bread
  • 12 eggs
  • 2 cups milk
  • 16 oz. cream cheese, softened
  • 1 tsp. vanilla (or flavor as desired)

Directions

  1. Cube the bread and set it aside.
  2. Mix the eggs, milk, cream cheese, and vanilla together in a bowl.
  3. Grease a 9x13 inch pan. Add 1 layer of bread cubes, spread evenly. Pour ½ of the liquid mixture evenly over the cubes. Repeat with the rest of the cubes and liquid.
  4. Refrigerate it overnight. Take it out in the morning and let it warm to room temperature (very important). Then bake it in the oven at 375° for 45 minutes.
Image of nutrition information for Stuffed French Toast including serving size of 229 grams, 6 servings per recipe, and 540 calories per serving.
Image of nutrition information for Stuffed French Toast including serving size of 229 grams, 6 servings per recipe, and 540 calories per serving.

You May Also Like

Use of Myrbetriq


MYRBETRIQ® (mirabegron extended-release tablets) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Do not take MYRBETRIQ if you are allergic to mirabegron or any ingredients in MYRBETRIQ.

MYRBETRIQ may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. You and your doctor should check your blood pressure while you are taking MYRBETRIQ. Call your doctor if you have increased blood pressure.

MYRBETRIQ may increase your chances of not being able to empty your bladder. Tell your doctor right away if you have trouble emptying your bladder or you have a weak urine stream. MYRBETRIQ may cause an allergic reaction with swelling of the face, lips, throat or tongue with or without difficulty breathing. Stop using MYRBETRIQ and go to the nearest hospital emergency room right away.

Tell your doctor about all the medicines you take including medications for overactive bladder or other medicines especially thioridazine (Mellaril™ and Mellaril-S™), flecainide (Tambocor®), propafenone (Rythmol®), digoxin (Lanoxin®) or solifenacin succinate (VESIcare®). MYRBETRIQ may affect the way other medicines work, and other medicines may affect how MYRBETRIQ works.

Before taking MYRBETRIQ, tell your doctor about all of your medical conditions, including if you have liver or kidney problems.

The most common side effects of MYRBETRIQ include high blood pressure, pain or swelling of the nose or throat (nasopharyngitis), urinary tract infection, and headache.

For further information, please talk to your healthcare professional and see accompanying Patient Product Information and complete Prescribing Information for MYRBETRIQ® (mirabegron extended‑release tablets).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Use of Myrbetriq


MYRBETRIQ® (mirabegron extended-release tablets) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Do not take MYRBETRIQ if you are allergic to mirabegron or any ingredients in MYRBETRIQ.

MYRBETRIQ may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. You and your doctor should check your blood pressure while you are taking MYRBETRIQ. Call your doctor if you have increased blood pressure.

MYRBETRIQ may increase your chances of not being able to empty your bladder. Tell your doctor right away if you have trouble emptying your bladder or you have a weak urine stream. MYRBETRIQ may cause an allergic reaction with swelling of the face, lips, throat or tongue with or without difficulty breathing. Stop using MYRBETRIQ and go to the nearest hospital emergency room right away.

Tell your doctor about all the medicines you take including medications for overactive bladder or other medicines especially thioridazine (Mellaril™ and Mellaril-S™), flecainide (Tambocor®), propafenone (Rythmol®), digoxin (Lanoxin®) or solifenacin succinate (VESIcare®). MYRBETRIQ may affect the way other medicines work, and other medicines may affect how MYRBETRIQ works.

Before taking MYRBETRIQ, tell your doctor about all of your medical conditions, including if you have liver or kidney problems.

The most common side effects of MYRBETRIQ include high blood pressure, pain or swelling of the nose or throat (nasopharyngitis), urinary tract infection, and headache.

For further information, please talk to your healthcare professional and see accompanying Patient Product Information and complete Prescribing Information for MYRBETRIQ® (mirabegron extended‑release tablets).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.